These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4979795)

  • 1. [Inhibitory effect of various sulfonamide drugs on the growth of Mycobacterium tuberculosis in vitro. 2].
    Tamura M; Yamazaki A; Yamazaki S
    Iryo; 1969 May; 23(5):646-51. PubMed ID: 4979795
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro study of inhibitory action of sulfa drugs on the growth of Mycobacterium tuberculosis. 3. Comparison of inhibitory actions of various sulfonamides on the strains pre-treated with sulfa drugs].
    Tamura M; Yamazaki M
    Iryo; 1969 Nov; 23(11):1431-40. PubMed ID: 4984169
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antitubercular action of prolonged use of sulfa drugs, with special reference to INH and results of its use in combination. I. In vitro experiments].
    SHIMIZU A
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1962 Sep; 11():75-80. PubMed ID: 13988525
    [No Abstract]   [Full Text] [Related]  

  • 4. The optimization and characterization of functionalized sulfonamides derived from sulfaphenazole against Mycobacterium tuberculosis with reduced CYP 2C9 inhibition.
    Chen H; Wang B; Li P; Yan H; Li G; Huang H; Lu Y
    Bioorg Med Chem Lett; 2021 May; 40():127924. PubMed ID: 33705901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new method of sensitivity testing of sulfonamides: "2-tube-indicator-test"].
    Zangger J
    Pathol Microbiol (Basel); 1965; 28(5):797-805. PubMed ID: 5837278
    [No Abstract]   [Full Text] [Related]  

  • 6. New Ni(II)-sulfonamide complexes: synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4].2H2O and [Ni(sulfapyridine)2].
    Mondelli M; Bruné V; Borthagaray G; Ellena J; Nascimento OR; Leite CQ; Batista AA; Torre MH
    J Inorg Biochem; 2008 Feb; 102(2):285-92. PubMed ID: 17976730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and mechanisms of action of drugs on microorganisms. VII. Quantitative adherence of sulfonamide action on microbial growth to a receptor-site model.
    Garrett ER; Wright OK
    J Pharm Sci; 1967 Dec; 56(12):1576-85. PubMed ID: 4871916
    [No Abstract]   [Full Text] [Related]  

  • 8. Antituberculous activity of isoniazid in combination with sulfisoxazole (Gantrisin). I. The effect of isoniazid-sulfisoxazole in vitro.
    NAITO M; WATANABE R; TSUKUMA S; IBA K
    Acta Tuberc Jpn; 1960 Sep; 10():47-56. PubMed ID: 13727549
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to sulfadiazine, sulfisoxazole and sulfathiazole.
    Casal M; Rodriguez F
    Eur J Clin Microbiol; 1984 Aug; 3(4):320-1. PubMed ID: 6489322
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusual cell form of Bacterium anitratum produced by sulfonamides.
    Brzin B
    Experientia; 1966 Mar; 22(3):149-50. PubMed ID: 5959919
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological properties of 4-sulfanilamido-3,6-dimethoxypyridazine (CS-61)--a new sulfonamide.
    Seki T; Segawa T; Komatsu T; Nakagome T
    Arzneimittelforschung; 1965 Dec; 15(12):1441-5. PubMed ID: 4960234
    [No Abstract]   [Full Text] [Related]  

  • 12. On the mechanism of the binding of sulfonamides to bovine serum albumin.
    Jardetzky O; Wade-Jardetzky NG
    Mol Pharmacol; 1965 Nov; 1(3):214-30. PubMed ID: 5842823
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pattern of resistance development of Mycobacterium tuberculosis to sulfisoxazole].
    TSUKAMURA M
    Kekkaku; 1960 May; 35():328-30. PubMed ID: 13839681
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
    Abate G; Koivula T; Hoffner SE
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A trial of treatment for pulmonary tuberculosis patients showing multiple resistance to anti-tuberculosis drugs. 1. A fundamental experiment of MIC of demethyl-chlortetracycline (LM) to M. tuberculosis and other mycobacteria].
    Takenaka T; Tsukamura M
    Kekkaku; 1970 Mar; 45(3):93-6. PubMed ID: 4987506
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of anti-tuberculosis drugs on the iron-sequestration mechanisms of mycobacteria.
    Raghu B; Sarma GR; Venkatesan P
    Indian J Pathol Microbiol; 1995 Jul; 38(3):287-92. PubMed ID: 8819661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of amikacin on Mycobacterium tuberculosis in vitro.
    Fodor T
    Acta Microbiol Acad Sci Hung; 1981; 28(4):419-20. PubMed ID: 6797266
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro sensitivity of the sulfonamides against atypical Mycobacteria (author's transl)].
    Hokama S
    Kekkaku; 1976 Jul; 51(7):287-91. PubMed ID: 966409
    [No Abstract]   [Full Text] [Related]  

  • 19. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
    Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
    J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the bacteriostatic and bactericidal activity of promin, diasone, sulfathiazole, sulfaguanidine and streptomycin on the H-37v. strain of M. tuberculosis.
    SASANO KT
    Am Rev Tuberc; 1949 Apr; 59(4):461-5. PubMed ID: 18125559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.